A randomized phase III study of neoadjuvant chemotherapy with docetaxel(D), oxaliplatin(O), and S-1(S) (DOS) followed by surgery and adjuvant S-1 vs. surgery and adjuvant S-1 for resectable advanced gastric cancer (PRODIGY)

Autor:	Young-Kyu Park, Ik-Joo Chung, Minkyu Jung, Seung Wan Ryu, Min-Hee Ryu, Yoon-Koo Kang, Mi-Jung Kim, Sang Cheul Oh, Jong Gwang Kim, Jeong Hwan Yook, Myeong-Cherl Kook, Sang Young Roh, Gyunji Kim, Jong Seok Lee, Jeehyun Lee, Kyoo Jung Shim, Young-Woo Kim, Samyong Kim, Hong-Suk Song, Sung Hoon Noh
Rok vydání:	2015
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Locally advanced Cancer Advanced gastric cancer Stage ii medicine.disease Surgery Oxaliplatin Docetaxel Internal medicine Medicine business Adjuvant medicine.drug
Zdroj:	Journal of Clinical Oncology. 33:TPS4136-TPS4136
ISSN:	1527-7755 0732-183X
Popis:	TPS4136 Background: Although adjuvant chemotherapy with S-1 is now considered a standard after D2 resection in stage II or III locally advanced gastric cancer (LAGC) in Asia, many patients still ex...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cfbe6e566397bf9b08d39bfbd1f4ac27 https://doi.org/10.1200/jco.2015.33.15_suppl.tps4136 Zobrazit plný text záznamu